Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression

US6451816B1 · kind B1 · utility

Assignee

• Klinge Pharma GmbH · DE

Inventors

• Elfi Biedermann · Vaterstetten, DE
• Max Hasmann · Schwanau, DE
• Roland Loser · Feldafing, DE
• Benno Rattel · Munich, DE
• Friedemann Reiter · Putzbrunn, DE
• Barbara Schein · Neufahrn, DE
• Klaus Seibel · Gräfelfing, DE
• Klaus Vogt · Munich, DE

Key dates

• Filing date: Dec 18, 1998
• Grant date: Sep 17, 2002
• Expiry date: Dec 18, 2018

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07F9/59
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to the use of pharmacologically valuable pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides according to general formula (I) in the treatment of tumors or for immunosuppression.